Accent Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200
Closed -$5.41K 433
2025
Q2
$5.41K Sell
200
-242
-55% -$7.01K ﹤0.01% 323
2025
Q1
$13.1K Hold
442
0.01% 182
2024
Q4
$17.5K Hold
442
0.01% 119
2024
Q3
$15K Buy
+442
New +$12.4K 0.01% 150

Other funds holding VCYT

Accent Capital Management's VCYT Position: Q3 2025 in Review

Accent Capital Management sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 200 shares — an estimated $5.41K sold.

Accent Capital Management first reported a position in VCYT in Q3 2024 and held it in 4 quarters. The position peaked at $17.5K in Q4 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Accent Capital Management reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Accent Capital Management sold 200 Veracyte shares in Q3 2025, an estimated $5.41K.
  • Accent Capital Management first reported a position in Veracyte in Q3 2024 and held it in 4 quarters.
  • Accent Capital Management's Veracyte position peaked at $17.5K in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Accent Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.